Ankle Kinesio Taping vs Mulligan's Mobilization With Movement

NCT03619629 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2018-11-15

No results posted yet for this study

Summary

The aim of the study is to compare the effects of Kinesio taping and Mulligan's mobilization with movement technique on balance, muscle strength and flexibility in healthy ankles . Patients will randomly be divided into 4 groups: Kinesio taping (KT) group, sham Kinesio taping (SKT) group, Mulligan's mobilization with movement (MWM) group and sham mobilization with movement (SMWM) group . Kinesiotape will be applied both ankles as "Correction technique" in KT group, 'Posterolateral glide mobilization with movement' will be applied 10 times to both ankles in MWM group. The evaluations will be repeated after waiting 45 minutes to reveal the effects of Kinesio taping and Mulligan mobilization with movement.

Conditions

  • Healthy

Interventions

OTHER

Kinesio-tape

Kinesiotape will be applied both ankles as "Correction technique".

OTHER

Mulligan's mobilization with movement

'Posterolateral glide mobilization with movement' will be applied 10 times to both ankles.

OTHER

Sham Kinesio-taping

Sham Kinesio-taping technique will be applied both ankles.

OTHER

Sham Mulligan's mobilization with movement

Sham Mulligan's mobilization with movement technique will be applied both ankles.

Sponsors & Collaborators

  • Dokuz Eylul University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-06
Primary Completion
2018-10-13
Completion
2018-10-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03619629 on ClinicalTrials.gov